HealthTrackRx develops monkeypox-specific PCR test with next-day results
July 26, 2022Manufacturing and Production
HealthTrackRx is now offering a molecular test for detection of the human monkeypox virus. The test was developed by the …
Shift in drinking patterns could lead to 150,000 more cases of disease in England
July 26, 2022Manufacturing and Production
New modelling research carried out by the Institute of Alcohol Studies (IAS) and Health Lumen, has found that if alcohol …
CHMP issues positive recommendation to first and only biologic for asthma patients
July 26, 2022Manufacturing and Production
AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the EU, as an add-on therapy in patients 12 years …
VistaGen’s social anxiety disorder treatment fails to meet primary endpoint in Phase III
July 25, 2022Sales and Marketing
VistaGen Therapeutics has announced topline data from its Phase III PALISADE-1 trial which shows that PH94B, its nasal spray candidate …
Recent hepatitis linked to adeno-associated virus AAV2
July 25, 2022Sales and Marketing
Recent acute hepatitis cases of unknown origin in children have now been linked to the virus AAV2 in two new …
Monkeypox declared global health emergency
July 25, 2022Sales and Marketing
For the second time in two years, WHO declared a global health emergency, this time for monkeypox. The declaration is …
MPs warn NHS in England facing worst staffing crisis in history
July 25, 2022Sales and Marketing
A recent report by MPs say that the large number of unfilled NHS job vacancies is posing a serious risk …
NICE recommend new early targeted treatment for breast cancer
July 22, 2022Medical Communications
Abemaciclib (Verzenios) has been approved by the NICE to treat some people with breast cancer that has a high-risk of …
£70 million in fines for pharma firms that overcharged NHS
July 22, 2022Medical Communications
The CMA has found that Pfizer and Flynn charged unfairly high prices for phenytoin sodium capsules for over four years, …
Otsuka receives positive CHMP opinion for lupus nephritis treatment
July 22, 2022Medical Communications
The CHMP has adopted a positive opinion relating to the use of Lupkynis (voclosporin) in combination with mycophenolate mofetil for …
Cancer Research UK agreement to advance cancer immunotherapy candidate
July 22, 2022Medical Communications
Cancer Research UK and Sosei Heptares have announced the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug …
UK scientists say they have found cancer driver in junk DNA
July 21, 2022Business Services
Scientists in the UK think they have understood the mechanism behind junk DNA, which is implicated in cancer. Junk DNA …
Strategic alliance for treatment of glaucoma
July 21, 2022Business Services
AbbVie and iSTAR Medical SA have announced a strategic transaction to further develop and commercialise iSTAR Medical’s MINIject® device. The …
First disease-modifying treatment for AADC deficiency
July 21, 2022Business Services
The European Commission (EC) has granted a marketing authorisation for Upstaza™ (eladocagene exuparvovec), the world’s first disease-modifying treatment for aromatic …
Transformational therapy cures bleeding disorder haemophilia B
July 21, 2022Business Services
Researchers have found that a single injection of a new gene therapy, called FLT180a, removed the need for people to …
Depression may not be caused by chemical imbalance
July 20, 2022Research and Development
A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
COVID-19 boosters to be offered to all over 50s this autumn
July 20, 2022Research and Development
All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …
Potential shortage of 140,000 nurses in NHS England by 2030
July 20, 2022Research and Development
According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …
TSB and CR Pharma partner for COVID-19 antibody therapy in China
July 20, 2022Research and Development
TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …
Brain cancer treatment receives Orphan Drug Designation
July 19, 2022Manufacturing and Production
The FDA has granted an Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of …
Latest content
FibroFind appoints Lee Borthwick as CEO
